Ozempic
Product Images NDC 50090-5138

Product Visual Gallery

This gallery contains 70 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 50090-5138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram showing the peptide sequence and lipid moiety of the active ingredient in Ozempic by A-S Medication Solutions, illustrating the molecular arrangement including amino acids and lipid side chains.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting plasma glucose levels (mg/dL) over 24 hours since the start of a breakfast meal, comparing Ozempic at doses of 0.5 mg and 1 mg against placebo baselines and end of treatment. The x-axis shows time in hours, and the y-axis shows plasma glucose concentrations.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing insulin secretion rate (pmol/kg/min) on the y-axis plotted against plasma glucose levels (mg/dL) on the x-axis. The graph compares different groups including OCMEP-C baseline, OCMEP-C 1 mg end of treatment, placebo baseline, placebo end of treatment, and healthy subjects with distinct line markers and styles.*

FDA Label Image

Figure 3 (Image 04)

A data table presenting relative exposure (Cavg) ratios and 90% confidence intervals for semaglutide exposure by intrinsic factors including sex, age groups, race, ethnicity, body weight categories, and renal impairment levels.*

FDA Label Image

Figure 4 (Image 05)

A chart showing relative exposure ratios with 90% confidence intervals for various co-administered medications including Metformin, S-warfarin, R-warfarin, Digoxin, Atorvastatin, Ethinylestradiol, and Levonorgestrel. Each medication's ratio centers around 1, with recommendations for no dose adjustment.*

FDA Label Image

Figure 5 (Image 06)

A line graph displaying HbA1c percentage over weeks post randomization for three treatment groups: Ozempic 0.5 mg, Ozempic 1 mg, and Sitagliptin. The x-axis represents weeks up to 56 weeks and multiple imputation (MI) time points, while the y-axis shows HbA1c (%) from 6.0 to 8.5. Lines indicate changes for each treatment group, with patient numbers listed below per group at various time points.*

FDA Label Image

Warning 1 (Image 07)

Packaging label for Ozempic, a pharmaceutical product labeled by A-S Medication Solutions. The label includes the product name "Ozempic" prominently and features the A-S Medication Solutions logo. The design incorporates a distinctive color scheme with some graphical elements but does not display dosage form, strength, or package size.*

FDA Label Image

Device 1 (Image 08)

An instructional diagram illustrating the parts of an Ozempic pen and NovoFine Plus needle. The image labels the pen cap, pen window, dose counter, dose pointer, dose selector, and dose button on the pen. It also shows the outer needle cap, inner needle cap, needle, and paper tab of the needle with guidance symbols such as a flow check symbol and a dashed line to guide dose selection.*

FDA Label Image

A (Image 09)

An instructional illustration depicting hands holding an Ozempic injector pen, showing the process of preparing or assembling the pen prior to use.*

FDA Label Image

B (Image 10)

An instructional illustration showing a hand holding a pen-like injector device. The image highlights the device's grip area and the positioning of the thumb and fingers, likely demonstrating how to hold or operate the injector.*

FDA Label Image

C (Image 11)

An instructional illustration showing how to use a pen injector, specifically demonstrating holding and preparing the device for injection by manipulating the pen cap and needle area, indicated by an arrow pointing to the action.*

FDA Label Image

D (Image 12)

An instructional illustration depicting a hand holding a prefilled injector pen, with a finger pressing the injection button. The image focuses on the correct technique for administering a dose using an injection device, likely associated with Ozempic.*

FDA Label Image

E (Image 13)

An instructional illustration showing a person holding a syringe or pen device with one hand while using the other hand to pull back the cap or protective cover from the needle. The image is likely part of medication administration instructions for the Ozempic product.*

FDA Label Image

F (Image 14)

An instructional illustration showing a hand holding a syringe and a vial, with an arrow indicating the direction to insert the needle into the vial. This likely depicts preparation or drawing of a medication, relevant to injectable drugs like Ozempic.*

FDA Label Image

Warning 2 (Image 15)

Ozempic 1.34 mg/mL solution in a pre-filled injector pen carton by A-S Medication Solutions. The label shows dosing information and highlights features of the pen, including its thickness and dose increments. Packaging includes numeric and graphical details relevant to product use.*

FDA Label Image

Dose 1 (Image 16)

Ozempic is a 0.5 mg/0.5 mL dose cartridge for injection. The label displays the brand name Ozempic prominently, with a dosage strength of 0.5 mg. It indicates use for subcutaneous injection and includes a barcode. The labeler is A-S Medication Solutions, with NDC 50090-5138 clearly shown. Additional administration and storage instructions are printed on the label.*

FDA Label Image

G (Image 17)

An instructional diagram showing a close-up of a pen-type device with a part labeled as the 'flow check symbol section.' The illustration highlights the area where flow check is indicated on the device.*

FDA Label Image

H (Image 18)

An instructional diagram showing a hand holding an Ozempic injection pen with an upward arrow, indicating preparation or dose setting action. The image includes a small circular icon in the top left corner.*

FDA Label Image

Warning 3 (Image 19)

Ozempic 0.5 mg/0.5 mL solution in a prefilled pen carton, labeled with the brand name Ozempic and dosage strength 0.5 mg/0.5 mL. The label includes a green and white color scheme with dosage information prominently displayed. The labeler is A-S Medication Solutions, and the product NDC is 50090-5138.*

FDA Label Image

Dash 1 (Image 20)

Packaging label of Ozempic by A-S Medication Solutions. The label features the brand name prominently with the company logo and product NDC 50090-5138. The design includes blue and white colors with a circular graphic element.*

FDA Label Image

I (Image 21)

An instructional illustration showing a close-up of a pen-type medication device with a dialed line indicating the dose setting. The image highlights the selection of a 1 mg dose, shown on the device display. An arrow points upwards, accompanying the instruction to align the dashed line.*

FDA Label Image

Warning 4 (Image 22)

Ozempic injectable pen packaging label showing a concentration of 2 mg per 3 mL. The label includes calibration markings and instructions for dosage measurement. The product is labeled by A-S Medication Solutions with NDC 50090-5138.*

FDA Label Image

J (Image 23)

An instructional illustration showing a person holding and adjusting a dose counter on a pen injector. The counter displays the number 1, indicating 1 mg left in the dose counter stopper, demonstrating proper dose setting technique.*

FDA Label Image

K (Image 24)

An anatomical illustration depicting the front and back views of a human torso, highlighting injection sites on abdomen and thighs. This diagram is commonly used to indicate appropriate areas for subcutaneous administration of medication.*

FDA Label Image

L (Image 25)

An instructional illustration showing a hand holding a device vertically with a downward pointing arrow below it, indicating the direction to hold or move the device. The background is light with a partial outline of a human figure in the upper right corner.*

FDA Label Image

M (Image 26)

An instructional diagram showing a hand holding and pointing a pen-type injector downward with an arrow indicating the direction of use. There is an inset close-up of the needle tip to emphasize correct positioning for injection, likely related to Ozempic medication delivery.*

FDA Label Image

N (Image 27)

An instructional illustration showing a hand holding a syringe with the text bubble indicating to "Count slowly: 1-2-3-4-5-6" for proper administration timing.*

FDA Label Image

O (Image 28)

An instructional illustration showing the tip of an injection pen with a downward-facing needle and a drop of liquid at the needle tip. A blue arrow points upward from the plunger area, indicating a step to be performed, likely priming or expelling air before injection.*

FDA Label Image

Warning 5 (Image 29)

Ozempic carton by A-S Medication Solutions featuring the Ozempic logo prominently. The packaging shows the product name and displays the image of a pen injector device. The overall design uses purple and white colors with a yellow highlight on the pen image, consistent with Ozempic branding.*

FDA Label Image

P (Image 30)

An instructional illustration showing a hand lifting or opening a blue cap from the top of a pen-type medication device, likely demonstrating the first step in preparing the device for use.*

FDA Label Image

Q (Image 31)

An instructional diagram showing a medication vial with an arrow indicating the removal of a protective cap from the top of the vial.*

FDA Label Image

R (Image 32)

An instructional illustration depicting a close-up of hands preparing an injection pen. It shows the user holding the Ozempic pen and attaching or handling a needle, highlighting the step of priming or preparing the device for use.*

FDA Label Image

S (Image 33)

An instructional illustration showing two steps involving a pen-like device. The first frame shows holding the device with an arrow pointing the cap to be pulled off. The second frame shows the device with the cap removed, and an arrow indicating to unscrew or remove the base part.*

FDA Label Image

Warning 6 (Image 34)

Ozempic 2 mg/mL in 1.5 mL injectable pen carton from A-S Medication Solutions. This packaging contains one prefilled pen designed for subcutaneous injection, with the active ingredient semaglutide. The label displays dosage strength, route, and manufacturer information prominently.*

FDA Label Image

Warning 7 (Image 35)

Ozempic 1 mg/0.5 mL prefilled disposable pen carton from A-S Medication Solutions. The label indicates the product name Ozempic and strength 1 mg/0.5 mL dosage form. The package includes 1 prefilled disposable pen with a 4 mL total volume.*

FDA Label Image

Qr1 (Image 36)

FDA Label Image

Bull 1 (Image 37)

FDA Label Image

Warning 8 (Image 38)

Ozempic 2 mg/mL injectable solution single-dose pen displayed alongside its packaging carton. The box and pen are orange with white and gray text. The labeler is A-S Medication Solutions, and the product NDC is 50090-5138.*

FDA Label Image

Device 2 (Image 39)

An instructional diagram of the Ozempic pen and NovoFine Plus needle showing labeled parts including the pen cap, pen window, dose counter, dose pointer, dose selector, dose button, flow check symbol, and dashed line guide on the pen. The needle components labeled are the outer needle cap, inner needle cap, needle, and paper tab.*

FDA Label Image

A (Image 40)

An instructional illustration showing a hand holding and twisting the cap of a pen injector, likely demonstrating how to prepare or uncap the device prior to use.*

FDA Label Image

B (Image 41)

An illustration showing a hand holding a pen-like medical injection device with the thumb positioned near the top, indicating a step in the use or handling of the device for further instructions or administration.*

FDA Label Image

C (Image 42)

An instructional illustration depicting a hand holding a pen-like device with a cap being removed by pulling it upwards. An arrow indicates the direction to remove the cap. The image is likely part of instructions for preparing or using a drug delivery pen.*

FDA Label Image

D (Image 43)

An instructional illustration showing a hand using a pen injector device, with a close-up on the needle area. The image appears to demonstrate the injection technique or device preparation step.*

FDA Label Image

E (Image 44)

An instructional illustration showing a hand holding a pen-type device and another hand pulling back a protective cap or cover from the device's tip, suggesting preparation for injection or usage.*

FDA Label Image

F (Image 45)

An instructional illustration showing a hand holding an injectable pen, with an arrow indicating the insertion of a needle into the pen. The image suggests the assembly or preparation of the injection device for use.*

FDA Label Image

Warning 9 (Image 46)

Ozempic pen injection packaging label by A-S Medication Solutions. The label prominently displays the proprietary name Ozempic and the product NDC 50090-5138. The label includes essential product information such as dosage form (pen injection) and features logos and contact information for the manufacturer and distributor. The design is primarily white with green and purple text elements.*

FDA Label Image

Dose 2 (Image 47)

Ozempic injection pen packaging labeled with proprietary name Ozempic. The label shows the distributor A-S Medication Solutions and includes dosage and administration instructions. The pen appears as a 2 mg/1.5 mL prefilled injectable pen with dosage increment markings visible on the dosing window. The design features a gray and orange cap with a white body.*

FDA Label Image

G (Image 48)

An instructional diagram showing a hand holding an injection pen with a close-up inset indicating the selection of the flow check symbol. The diagram demonstrates where to look on the device to confirm the correct symbol is selected before use.*

FDA Label Image

H (Image 49)

An instructional illustration showing a hand holding an Ozempic injector pen. The image depicts pressing a button on the top of the pen and an arrow indicating upward movement, likely demonstrating preparation or dosage delivery steps.*

FDA Label Image

Warning 10 (Image 50)

Ozempic 1.34 mg/1.5 mL injection cartridge carton labeled with A-S Medication Solutions as the labeler. The carton shows a purple and blue color scheme with text indicating the product name and dosage form. The package contains 1.5 mL cartridges and displays the 50090-5138 NDC code.*

FDA Label Image

Dash 2 (Image 51)

The image shows a white carton box for Ozempic by A-S Medication Solutions. The front displays the brand name Ozempic in large letters at the top, with minimal other visible text and no dosage or strength clearly readable. The box design includes a mostly plain white background with a faint pattern at the upper left corner.*

FDA Label Image

I (Image 52)

An instructional illustration showing a close-up of fingers holding and interacting with a dosing device. The image highlights a dialed-in line with an example dose selection of 0.25 mg and a selected dose of 0.5 mg, likely related to dose adjustment for the product Ozempic.*

FDA Label Image

Warning 11 (Image 53)

FDA Label Image

J (Image 54)

An instructional illustration showing a hand holding and preparing an Ozempic injection pen. The example highlights the dose counter stopped at 0.25 mg, indicating how to read the dosage on the pen.*

FDA Label Image

K (Image 55)

An instructional illustration showing front and back views of a human torso labeled with markings indicating the recommended injection sites for the medication Ozempic. Sites are localized around the abdomen and outer thigh areas.*

FDA Label Image

L (Image 56)

An instructional illustration showing a hand holding a pen-like device with the blue end pointing downward, positioned near the skin of an abdomen, indicating an injection or administration step involving downward motion.*

FDA Label Image

M (Image 57)

Illustration showing a hand holding a pen-like injector device with the cap being removed. This image likely demonstrates how to prepare or use the injector for medication delivery.*

FDA Label Image

N (Image 58)

Illustration showing a hand holding a syringe or pen injector with a speech bubble indicating to count slowly from 1 to 6. This likely depicts instructions for administration pacing or dosage steps.*

FDA Label Image

O (Image 59)

An instructional illustration showing a close-up of a pen injector needle with a droplet at the tip and an upward arrow indicating removal or detachment of the cap or needle cover.*

FDA Label Image

Warning 12 (Image 60)

Ozempic carton by A-S Medication Solutions with NDC 50090-5138. The label shows the Ozempic brand name prominently. Additional text and graphics are present but not legible in the image provided.*

FDA Label Image

P (Image 61)

An instructional illustration showing a hand removing a cap from the top of a pen injector device by pulling it upward. The blue arrow indicates the direction to pull the cap off. This image likely demonstrates the initial step for preparing the Ozempic pen for use.*

FDA Label Image

Q (Image 62)

An instructional image showing a hand holding a small device or cap above an open container with a cross-slit opening, depicting the action of inserting or placing the device into the container. A large downward arrow indicates the direction of movement.*

FDA Label Image

R (Image 63)

An instructional illustration showing a person using their thumb and index finger to hold and prepare a medical pen injector device, likely demonstrating the proper technique for handling or administering a dose.*

FDA Label Image

S (Image 64)

An instructional diagram showing a needle cap being removed from a pen-like device, likely representing a step in preparing an injectable medication such as Ozempic. The image uses arrows to indicate the direction of removal.*

FDA Label Image

Warning 13 (Image 65)

Ozempic 0.5 mg/0.5 mL injectable solution in a 2 mL cartridge carton, labeled for use with Novo Nordisk pen needles. The packaging shows the product name, strength, dosage form, quantity (2 mL cartridge), and labeler A-S Medication Solutions.*

FDA Label Image

Warning 14 (Image 66)

Ozempic carton by A-S Medication Solutions. The packaging shows Ozempic in a multicolor design featuring red, white, and purple sections. The label prominently displays the proprietary name Ozempic with no visible active ingredient, strength, or dosage form. The NDC 50090-5138 is associated with this product.*

FDA Label Image

Qr2 (Image 67)

FDA Label Image

Bull 2 (Image 68)

FDA Label Image

Figure 6 (Image 71)

A line graph depicting the percentage of patients with events over time in weeks from randomization, comparing Ozempic and placebo groups. The graph shows event rates increasing over approximately 109 weeks, with the Ozempic group having a lower percentage of patients with events than the placebo group. Patient counts at risk for both groups are listed below the graph at various time points.*

FDA Label Image

Label Image (Lbl500905138)

Ozempic (semaglutide) injection 2 mg/1.5 mL, 1.5 mg/mL, refill pen by A-S Medication Solutions. The label states the product contains two pens, refrigerated storage requirements, and notes the package includes NovoFine Plus 32G needles and product literature. The NDC is 50090-5138-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.